Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,960 | 72,301 | 63,608 | 48,282 | 53,514 |
| TOTAL | $83,171 | $73,747 | $64,925 | $49,180 | $54,508 |
| Non-Current Assets | |||||
| PPE Net | 329 | 293 | 312 | 87 | 90 |
| Investments And Advances | 50 | 50 | 50 | 50 | 50 |
| Other Non-Current Assets | 904 | 1,007 | 1,110 | 1,210 | 1,310 |
| TOTAL | $1,283 | $1,350 | $1,472 | $1,347 | $1,450 |
| Total Assets | $84,454 | $75,097 | $66,397 | $50,527 | $55,958 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,426 | 3,727 | 4,340 | 4,223 | 4,092 |
| TOTAL | $3,873 | $4,164 | $4,767 | $4,680 | $4,656 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 62 | 154 | 245 | 333 | 419 |
| TOTAL | $82 | $197 | $311 | $420 | $528 |
| Total Liabilities | $3,955 | $4,361 | $5,078 | $5,100 | $5,184 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,331 | 20,195 | 19,246 | 13,587 | 13,585 |
| Common Shares | 21 | 19 | 18 | 14 | 13 |
| Retained earnings | -241,315 | -236,294 | -230,974 | -224,594 | -219,054 |
| TOTAL | $80,499 | $70,736 | $61,319 | $45,427 | $50,774 |
| Total Liabilities And Equity | $84,454 | $75,097 | $66,397 | $50,527 | $55,958 |